EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Seroprevalence of hepatitis C virus in blood donors from Antioquia-Colombia, 2012-2024

Jaiberth Antonio Cardona-Arias, Valeria Rúa-Rico, Carolina Gómez-Holguín, Valeria Rojas-Vega

Journal of Public Health Research · 2026-10 · 15 (4)

DOI: 10.1177/22799036261508882 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Public Health Research, online erschienen am 20.11.2026. Verfasst von Jaiberth Antonio Cardona-Arias und 3 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Universidad de Antioquia.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hepatitis C virus (HCV) affects approximately 1% of world population. In Colombia, blood banks are determinant for epidemiological surveillance in asymptomatic and low-risk populations.

Objective

To determine the seroprevalence of HCV, its spatial-temporal distribution, and associated factors in blood donors from Antioquia-Colombia, 2012-2024.

Methods

Serial cross-sectional study with 236,896 subjects. Seroprevalence by period, year and municipality was determined. Associated factors were identified using the chi-square test, and the strength of association was determined using adjusted odds ratios with logistic regression. Analyses were performed in SPSS 29.0.

Results

The period seroprevalence of HCV was 4.5/1000 donors, since 2020 has been less than 4/1000. In spatial distribution 25 municipalities reported no cases of HCV, 14 had a low seroprevalence (2.0-3.8/1000), in Metropolitan area it was moderate (4.3-4.4/1000), and 26 municipalities had high seroprevalence (≥5.5/1000). The highest specific seroprevalences were observed in donors over 59 years of age (5.5/1000), unemployed individuals (5.0/1000), housewives (5.3/1000), first-time donors (6.0/1000), and replacement donors (5.4/1000). Odds of infection were higher in elderly (OR: 1.7; 95% CI 1.3-2.2, compared to young people), and first-time donors (OR: 2.2; 95% CI 1.8-2.6, compared to repetitive donors).

Conclusion

The period seroprevalence of HCV was 4.5/1000, spatial-temporal trends in infection were presented, subgroups with a higher proportion of cases were identified. This evidence is important for targeting health education actions, prioritizing groups for screening, and understanding the endemic levels of the virus in the low-risk population.

Förderung

  • Universidad de Antioquia

Zitieren

APA

Cardona-Arias, J. A., Rúa-Rico, V., Gómez-Holguín, C., & Rojas-Vega, V. (2026). Seroprevalence of hepatitis C virus in blood donors from Antioquia-Colombia, 2012-2024. Journal of Public Health Research, 15(4). https://doi.org/10.1177/22799036261508882

Vancouver

Cardona-Arias JA, Rúa-Rico V, Gómez-Holguín C, Rojas-Vega V. Seroprevalence of hepatitis C virus in blood donors from Antioquia-Colombia, 2012-2024. Journal of Public Health Research. 2026;15(4). doi:10.1177/22799036261508882

BibTeX
@article{CardonaArias2026,
  author = {Cardona-Arias, Jaiberth Antonio and Rúa-Rico, Valeria and Gómez-Holguín, Carolina and Rojas-Vega, Valeria},
  title = {Seroprevalence of hepatitis C virus in blood donors from Antioquia-Colombia, 2012-2024},
  journal = {Journal of Public Health Research},
  year = {2026},
  volume = {15},
  number = {4},
  doi = {10.1177/22799036261508882}
}
Kostenlos starten →